EC Dental Science

CIC rearranged sarcoma configures as an undifferentiated, small round cell soft tissue sarcoma with capicua-double homeobox 4 (CIC-DUX4) genetic fusion. The extremely exceptional, high grade, aggressive CIC rearranged sarcoma emerges as an undifferentiated small round cell sarcoma demonstrating CIC genetic fusions, commonly a CIC-DUX4 genomic fusion.

Clinical representation, histological countenance, immunological profile, molecular characteristics and genetic signature of CIC rearranged sarcoma is diverse from Ewing sarcoma and associated tumours. However, appropriate discernment of confirmatory molecular genomic fusion of CIC gene is necessitated. The sarcoma preponderantly incriminates paediatric subjects or young adults.

1. Mancarella C., et al. “CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers”. Cancers 21 (2022): 5411.
2. Brahmi M., et al. “Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group”. Cancer Medicine 7 (2024): 7801-7807.
3. Yang J., et al. “Primary retroperitoneal perirenal CIC rearrangement sarcoma: A case report”. Oncology Letters 3 (2022): 322.
4. Kojima N., et al. “Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall”. Modern Pathology 10 (2022): 1439-1448.
5. Connolly EA., et al. “Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review”. Cancer Medicine 8 (2022): 1805-1816.
6. Image 1 Courtesy: Pathology outlines.
7. Image 2 Courtesy: American journal of case reports.